BioMérieux SA Financials

Market Capitalization €11.58 Billion as of Jan. 1, 2025

Valuations Metrics as of Jan. 25, 2025

Trailing PE	28.30
Forward PE	21.49
Price to Sales TTM	€3.04
Price to Book MRQ	€3.00
Enterprise to Revenue	3.11
Enterprise to EBITDA	13.70

Financial Reports as of Jun. 30, 2018

Financials

Fiscal Year Ends	2023-12-31
Most Recent Quarter	2018-06-30
Profit Margin	10.81%
Operating Margin	15.16%
Return on Assets TTM	7.08%
Return on Equity TTM	10.61%

Income Statement

Revenue TTM	€3,806,500,096
Revenue per Share TTM	€32.26
Quarterly Revenue Growth	7.40%
Gross Profit TTM	€2,057,200,000
EBITDA	€830,400,000
Net Income to Common TTM	€411,300,000
Diluted EPS TTM	€3.47
Quarterly Earnings Growth YoY	33.20%

Balance Sheet

Total Cash MRQ	€272,200,000
Total Cash per Share MRQ	€2.31
Total Debt MRQ	€
Total Debt to Equity MRQ	14.39
Current Ratio MRQ	2.21
Book Value per Share MRQ	€32.78

Cash Flow

Operating Cash Flow TTM	€494,600,000
Levered Free Cash Flow TTM	€180,712,496

BIM Stock Info as of Jan. 25, 2025

Stock Statistics

Shares Outstanding	117,929,000
Float Shares	43,727,050
Avg 10 Volume	65,993
Avg 30 Volume	None
Shares Short	None
Short Ratio
Short % of Shares	%
% Held by Insiders	63.59%
% Held by Institutions	20.59%

Stock Price Summary

Beta	0.22
Fifty Two Week Low	€88.25
Fifty Two Week High	€114.70
Fifty Two Week Change	10.03%
Day 50 MA	€102.71
Day 200 MA	€99.66

Dividends and Splits

Forward Annual Dividend Rate	€3.40
Forward Annual Dividend Yield	3.02%
Trailing Annual Dividend Rate	€0.85
Trailing Annual Dividend Yield	0.75%
Payout Ratio	24.50%
Dividend Date
Ex Dividend Date	2024-06-07
Last Split Factor
Last Split Date	2017-09-20